Production (Stage)
Lotus Bio-Technology Development Corp.
LBTD
$0.00
$0.000.00%
OTC PK
| 12/31/2017 | 09/30/2017 | 06/30/2017 | 03/31/2017 | 12/31/2016 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
|
|||||
| Total Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Property, Plant & Equipment | -- | -- | -- | -- | 3.80K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 0.00 | 0.00 | 0.00 | 0.00 | 3.80K |
|
|
|||||
| Total Accounts Payable | 10.20K | 11.00K | 11.70K | 11.70K | 20.30K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 16.70K | 70.20K | 69.20K | 69.20K | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 67.40K |
| Total Other Current Liabilities | -- | -- | -- | -- | 67.40K |
| Total Current Liabilities | 26.80K | 81.20K | 80.90K | 80.90K | 87.80K |
|
|
|||||
| Total Current Liabilities | 26.80K | 81.20K | 80.90K | 80.90K | 87.80K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 16.70K | 70.20K | 69.20K | 69.20K | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 26.80K | 81.20K | 80.90K | 80.90K | 87.80K |
|
|
|||||
| Common Stock & APIC | 938.10K | 883.10K | 868.10K | 868.10K | 868.10K |
| Retained Earnings | -964.90K | -964.30K | -949.00K | -948.90K | -952.10K |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -26.80K | -81.20K | -80.90K | -80.90K | -84.00K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -26.80K | -81.20K | -80.90K | -80.90K | -84.00K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -26.80K | -81.20K | -80.90K | -80.90K | -84.00K |
|
|
|||||